Last reviewed · How we verify
NCT03939650
Diagnosis Assessment With Diaana #3
NA trial testing Diaana in Decision Making. Withdrawn.
31 January 2020
Quick facts
| Lead sponsor | Adrien Schwitzguebel |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 31 January 2020 |
| Primary completion | 31 January 2020 |
| Estimated completion | 31 January 2020 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Diaana
Conditions studied
- Decision Making — all drugs for Decision Making →
- Computer-assisted — all drugs for Computer-assisted →
- General Practitioners — all drugs for General Practitioners →
- Patient Engagement — all drugs for Patient Engagement →
Sponsor
Adrien Schwitzguebel
Who can join
Adults 16 to 65, any sex, with Decision Making or Computer-assisted. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single-center, unblinded, 2:1 parallel pseudo-randomized efficacy trial. In the intervention group only, resident physicians will be assisted by the automated medical history-taking device "Diaana" during their consultations in outpatient ambulatory unit of the Geneva University Hospital. In both groups, the differential diagnosis of the resident physician will be compared to the gold-standard diagnosis of the senior physician.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03939650
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diaana
Trials testing the same drug.
- NCT03901495 — DD Assessment With Diaana #2 · NA · completed
Other recruiting trials for Decision Making
Currently open trials in the same condition.
- NCT06375551 — K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions · NA · recruiting
- NCT06852170 — Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev · NA · recruiting
- NCT06735417 — Impacts of the Indashyikirwa Program on Intimate Partner Violence in Syria · NA · active not recruiting
- NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting
- NCT06638554 — Integrating Telehealth to Advance Lung Cancer Screening · NA · recruiting
Other Adrien Schwitzguebel trials
Trials by the same sponsor.
- NCT03901495 — DD Assessment With Diaana #2 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03939650 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Adrien Schwitzguebel
- Last refreshed: 23 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03939650.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing